The activated c-Ha-ras oncogene induced
The nuclear protooncogene c-jun was originally identified as a cellular homologue of the transforming gene of an avian retrovirus, avian sarcoma virus 17 (1) . The product of the gene, Jun protein, forms a heterodimer with Fos, the product of the c-fos nuclear protooncogene and its family, to become a transcriptional activator protein, AP1, which recognizes and binds to an AP1 consensus sequence (reviewed in refs. 2 and 3). When quiescent cells are stimulated by serum growth factors, very rapid and transient expression of c-fos and c-jun is observed. AP1 is also known to respond to a tumor promoter, phorbol 12-myristate 13-acetate (PMA), and to enhance gene expression (4, 5) . Therefore, AP1 is considered to play a key role in switching on the gene expression that ultimately leads to DNA replication and cell division. More recently, AP1 has been implicated as a regulator of DNA replication (6) . Here we present evidence that AP1 is also involved in the initial stage of cell differentiation.
The murine embryonal carcinoma cell line F9 has been used widely to study the mechanism of gene regulation in the process of cell differentiation (7) , since F9 cells can be induced to differentiate to endoderm-like cells by retinoic acid and cAMP (8) . AP1 is undetectable in F9 cells, whereas it is easily detectable after differentiation of the cells (9) . The expression of both c-jun and c-fos is very low in F9 cells (10) . An interesting question is whether AP1 becomes detectable as a consequence of differentiation or whether AP1 is required for cell differentiation. Muller and Wagner reported in 1984 (11) that the overexpression of c-fos in F9 cells induced F9 cell differentiation. However, only a small fraction of the cells expressing c-fos underwent differentiation, regardless of the levels of c-fos expression (12) . Moreover, the phenotype of the differentiated cells was somewhat different from that of the cells induced to differentiate by retinoic acid (11) .
The activated Ha-ras oncogene [Ha-ras(Val-12)] and PMA stimulate the DNA binding of murine AP1, PEBP1 (13) , or PEA1 (14) in lymphoid cells and in fibroblasts (15, 16) . PMA superinduces the transcriptional activating function of AP1 in the presence of protein synthesis inhibitors by posttranslational modification of the proteins (17) . On the other hand, the mechanism of the induction of AP1 by Ha-ras(Val-12) has not been studied in detail.
Here we show that Ha-ras(Val-12) induces c-jun expression and the AP1 DNA-binding activity in F9 cells. This finding allowed us to analyze whether AP1 would induce F9 cell differentiation.
MATERIALS AND METHODS
Cell Culture. F9 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%6 (vol/vol) fetal bovine serum at 370C in humidified 10% C02/90% air.
Plasmids. The chloramphenicol acetyltransferase (CAT)
gene constructs used were pA10CAT2 derivatives, p(WA)2-CAT and p(MlA)2-CAT through p(M4A)2-CAT, in which the CAT gene is regulated by the simian virus 40 (SV40) early promoter under the control of dimers of the polyomavirus A element or a mutated A element (16) . pT24c3 is a recombinant plasmid harboring Ha-ras(Val-12) (18) . pHfARJ101, in which rat c-jun derived from pRJ101 (19) is regulated by the human 8-actin enhancer and promoter, was constructed by inserting a 2010-base-pair (bp) EcoRI fragment of rat c-jun cDNA into the HindIII-BamHI sites of the mammalian expression vector pHPAPr-1 (20) . pHfBARJ101(tr) is a frameshift mutant of pHl3ARJ101 in which 2 bp were inserted at the Acc I site in the c-jun coding region by restriction enzyme digestion at this site, filling the sticky ends with appropriate nucleotides, and religation. This insertion resulted in the truncation of the c-jun product. pSV2neo contains the neomycin-resistance gene driven by the SV40 enhancer and promoter (21 (16) (18), a 2.0-kbp EcoRI fragment of pRJ101 (19) , or a 0.8-kbp Pst I-Kpn I fragment of pAL41 that harbors mouse skeletal muscle f-actin cDNA (23), respectively, was used. Hybridized filters were washed twice in 2x SSC/0.5% SDS for 30 min at room temperature and twice in 0.1 x SSC/0.5% SDS for 30 min at 43°C.
RESULTS
Induction of the AP1-Site DNA-Binding Activity by Haras(Val-12). The DNA-binding activity of murine AP1, PEBP1 (13), or PEA1 (14) can be enhanced by transiently expressed Ha-ras(Val-12) (13, 15) . To analyze this enhancement in detail, Ha-ras(Val-12) was transfected into F9 cells in which AP1/PEBP1 was undetectable (9) . The AP1/PEBP1 DNA-binding activity was monitored using the A element of the polyomavirus enhancer as a probe (Fig. 1) . The A element represents one of the two cores of the enhancer and contains the three sequence motifs recognized by PEBP1 (PEA1), PEBP2/3 (PEA2), and PEBP5 (PEA3) (16) . Since there is no need to distinguish PEBP1 (PEA1) from AP1 for the discussion in the present study, the term AP1 will be used throughout the rest of this paper to indicate the factor(s) that binds to the AP1 consensus sequence, including PEBP1 (PEA1). When the CAT construct that was under the control of the A-element dimer was transfected, the CAT activity became detectable only after cotransfection with Ha-ras(Val-12) (Fig.  1, lanes 1 and 2) . Introduction of pairwise mutations in the (41) . Mutations in the PEBP2/3 site increased the response to Ha-ras(Val-12) nearly 10-fold (compare lanes 2 and 10). This is related to the derepression response observed by Wasylyk et al. (24) and has been discussed fully elsewhere (25) . The backbone vector containing no insert did not respond to cotransfected Ha-ras(Val-12) (lanes 11 and 12) .
The induction of the AP1 DNA-binding activity by Haras(Val-12) was also examined by mobility-shift assay. Whole cell extract was prepared from F9 cells that were cotransfected with pSV2neo and Ha-ras(Val-12) and selected with G418 for 4 days. The extract was incubated with a 32P-labeled A-element probe and analyzed by mobility-shift assay (Fig. 2, lanes 3-10) . The slowly migrating band represents AP1, since its formation was specifically abolished by inclusion of excess amounts of the AM oligonucleotide as a competitor in the binding reaction but was not affected by the inclusion of the AE oligonucleotide. The AM and AE oligonucleotides represent the AP1 and PEBP2/3 binding sites, respectively (Fig. 2 
Induction of c-jun Gene Expression by Ha-ras(Val-12).
To analyze the mechanism of induction of AP1 activity by Ha-ras(Val-12), poly(A)+ RNA was prepared from F9 cells 20 hr after transfection with Ha-ras(Val-12). Northern analysis with c-jun-specific 32P-labeled DNA revealed that the amount of the 2.7-kilobase (kb) c-jun-specific transcript was significantly higher in Ha-ras(Val-12) transfectants than in control cells (Fig. 3) . By densitometric scanning of the autoradiogram, the increase in the c-jun transcript was calculated to be 2.4-fold after normalization using an internal control of p8-actin transcript. The efficiency of transfection was found to be 1% by transfecting a parallel culture with the lacZ gene driven by the long terminal repeat (LTR) promoter of the Rous sarcoma virus and subsequently counting the number of cells stained blue after the addition of 5-bromo-4-chloro-3-indolyl 13-D-galactoside. By taking this transfection efficiency into consideration, the overall increase of c-jun expression by Ha-ras(Val-12) was estimated to be 140-fold. The c-fos tran- (Fig. 4A, c) .
The induction of AP1 activity by Ha-ras(Val-12) appeared to precede the morphological differentiation of F9 cells (24-36 hr vs. 4-6 days). Hence, a causative role ofAP1 in this differentiation was envisaged. As mentioned earlier, the introduction of c-fos into F9 cells induced differentiation but only partially (12) . Therefore, we tested the effect of c-jun. The morphological differentiation of c-jun-transfected F9 cells was very similar to that of Ha-ras(Val-12)-transfected F9 cells (Fig. 4A, a) . As a control, we also transfected a plasmid that has the potential to express a truncated form of the Jun protein that lacks the DNA-binding domain. The morphology of such F9 cells (Fig. 4A, b) was indistinguishable from that of parental F9 cells. We also observed no morphological change in F9 cells when the nonactivated c-Ha-ras protooncogene was introduced (data not shown).
Northern analysis of the RNAs extracted from the c-jun-or mutant c-jun-transfected cells 20 hr after transfection revealed the expected 2.0-kb c-jun-specific RNA (Fig. 5, lanes  2 and 3) . The amounts of each transcript detected were comparable, indicating that the wild-type and the mutated c-jun genes were transfected and expressed at about the same efficiency. Since relatively small amounts of poly(A)+ RNA were loaded on the gel compared to that used in Fig. 3 (Fig. 4B, lb) but was completely absent from Ha-ras(Val-12)-(lc) or c-jun-(la) transfected cells.
The expression of several differentiation marker proteins including laminin (27) , plasminogen activator (8) , and a heat shock protein, Hsp47, which is associated with collagen type IV (28) , were also examined. Cytoplasmic laminin (Fig. 4B,  2a and 2c ) and Hsp47 (3a and 3c) were detectable by indirect immunofluorescence in cells transfected with c-jun or Haras(Val-12) but were undetectable in cells transfected with mutated c-jun (2b and 3b). Plasminogen activator was similarly induced in c-jun or Ha-ras(Val-12)-transfected cells (Fig. 4C, a and c) inal F9 cell population, since the increase in the number ofthe cells secreting plasminogen activator after transfection of these genes (Fig. 4c, laminin expression in c-fos-transfected F9 cells (11) might be due to low levels of Fos/Jun complexes, even if they are formed, in the cells. Regardless of the mechanism, our observation, together with that of Muller and Wagner (11) demonstrates that AP1 can act as an inducer of F9 cell differentiation.
An important question to be answered is whether AP1 is involved when retinoic acid induces F9 cell differentiation. We used a strong promoter to express c-jun in the present study. How faithfully our results represent the physiological processes induced by retinoic acid would have to be carefully evaluated. Within the limits of the present study, however, the phenotype of the cells induced to differentiate by c-jun is similar to that after retinoic acid induction. Adenovirus ElA protein can also induce the partial differentiation of F9 cells (32) . It is necessary to examine whether the ElA gene induces c-jun expression.
The expression of c-myc rapidly decreases as F9 cells differentiate. Since antisense c-myc RNA induces F9 differentiation, c-myc appears to have an active role in maintaining F9 cells in an undifferentiated state (33) . It is interesting that the silencer found in the regulatory region of human c-myc harbors the AP1 binding site to which a factor containing Fos binds (34) . The role of AP1 might be to inhibit the expression of c-myc in this case.
Neuronal differentiation of a pheochromocytoma cell line, PC12, can be induced by nerve growth factor (35) or by introducing activated Ha-ras into the cells (36, 37) . There are some apparent similarities in gene regulation between F9 and PC12 cells during differentiation. Treatment of PC12 cells with nerve growth factor transiently induces the expression of both c-fos and c-jun (38) . The induction of PC12 differentiation by Ha-ras(Val-12) also appears to be mediated by AP1, since the transcriptional activating function of AP1 can be induced by Ha-ras in the cells (39) . In this case, the transcription of c-fos is augmented by Ha-ras(Val-12) and the activation occurs through the serum-responsive element in the c-fos regulatory region (39) . When both F9 and PC12 differentiation are taken into consideration, it appears that AP1 is involved in triggering cell differentiation at multiple levels of the developmental hierarchy.
It must be noted, however, that AP1 may antagonize the process of cell differentiation in a different situation. Introduction of c-fos or activated ras has been reported to suppress the MyoDi-induced differentiation of C2 fibroblasts into myoblasts (40) .
AP1 has been shown to play an essential role in growth regulation and oncogenesis (2, 3) . The present study and those from other laboratories suggest that it has an important role in developmental regulation as well.
